Takeda Pharmaceutical
338 hedge funds and large institutions have $2.53B invested in Takeda Pharmaceutical in 2019 Q4 according to their latest regulatory filings, with 65 funds opening new positions, 86 increasing their positions, 104 reducing their positions, and 38 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
3% more call options, than puts
Call options by funds: $95.2M | Put options by funds: $92.8M
0.81% less ownership
Funds ownership: 9.05% → 8.24% (-0.81%)
17% less repeat investments, than reductions
Existing positions increased: 86 | Existing positions reduced: 104
Holders
338
Holding in Top 10
6
Calls
$95.2M
Puts
$92.8M
Top Buyers
| 1 | +$61.9M | |
| 2 | +$22.8M | |
| 3 | +$6.73M | |
| 4 |
Millennium Management
New York
|
+$6.65M |
| 5 |
Renaissance Technologies
New York
|
+$5.99M |
Top Sellers
| 1 | -$162M | |
| 2 | -$45.4M | |
| 3 | -$36.9M | |
| 4 |
D.E. Shaw & Co
New York
|
-$28.9M |
| 5 |
SGA
Sector Gamma AS
Oslo,
Norway
|
-$15.5M |